Oxidative damage indices for the assessment of subclinical diabetic macrovascular complications

British Journal of Biomedical Science

Volumn 65, Issue 3, 2008, Pages 136-141

  Nwose, E U ^a   Richards, Ross S ^a   Kerr, P G ^b   Tinley, P ^a   Jelinek, H ^a  

^a CHARLES STURT UNIVERSITY   (Australia)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Antioxidants; Cardiovascular diseases; Diabetes mellitus

Indexed keywords

CHOLESTEROL; D DIMER; GLUCOSE; GLUTATHIONE; HOMOCYSTEINE; MALONALDEHYDE; METHEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD VISCOSITY; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE COURSE; DISEASE MARKER; ERYTHROCYTE LEVEL; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS OF VARIANCE; OXIDATIVE STRESS; PATHOGENESIS; POST HOC ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

EID: 53849091690     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2008.11732817     Document Type: Article

References (38)

1. Smith DA. Atherosclerotic cardiovascular disease: emerging laboratory risk factors (Preface) Clin Lab Med 2006; 26 (3): ix-xi.
2. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84 (4): 1381-478.
3. Gavat V, Voroniuc O. Oxidative stress and antioxidants in the diet in pathological processes at the level of the cardiovascular system (in Romanian). Rev Med Chir Soc Med Nat Iasi 1999; 103 (1-2): 37-41.
4. Tapsell LC, Hemphill I, Cobiac L et al. Health benefits of herbs and spices: the past, the present, the future. Med J Aust 2006; 185 (4 Suppl): S4-24.
5. Chaves PHM, Kuller LH, O'Leary DH, Manotio TA, Newman AB. Subclinical cardiovascular disease in older adults: insights from the cardiovascular health study. Am J Geriatr Cardiol 2004; 13 (3): 137-51.
6. Day SM, Duquaine D, Mundada LV et al. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 2003; 107 (20): 2601-6.
7. Lowe GD. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 2006; 133 (3): 232-50.
8. Lowe GD. Can haematology laboratories predict thrombosis? Clin Lab Haematol 2001; 23 (5): 335-54.
9. Nwose EU, Jelinek HF, Richards RS, Kerr PG. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complication. Br J Biomed Sci 2007;64 (1): 35-43.
10. Yang ZC, Xia K, Wang L et al. Asymmetric dimethylarginine reduced erythrocyte deformability in streptozotocin-induced diabetic rats. Microvasc Res 2007; 73 (2): 131-6.
11. Higgins C. Recurrence of venous thromboembolism. The Biomedical Scientist 2006; 50 (10): 865-7.
12. Nwose EU, Jelinek HF, Richards RS, Kerr PG. Erythrocyte oxidant stress and homocysteine in diabetes progression to cardiovascular co-morbidity (Abstract). Heart Foundation Conference and Scientific Meeting, Sydney 2006;: 33.
13. Jialal I, Devaraj S. Scientific evidence to support a vitamin E and heart disease health claim: research needs. J Nutr 2005; 135 (2): 348-53.
14. Akbartabartoori M, Lean ME, Hankey CR. Smoking combined with overweight or obesity markedly elevates cardiovascular risk factors. Eur J Cardiovasc Prev Rehabil 2006; 13 (6): 938-46.
15. Djousse L, Ellison RC, Beiser A, Scaramucci A, D'Agostino RB, Wolf PA. Alcohol consumption and risk of ischemic stroke: The Framingham Study. Stroke 2002; 33 (4): 907-12.
16. Cheng C, Kushner H, Falkner BE. The utility of fasting glucose for detection of prediabetes. Metabolism 2006; 55 (4): 434-8.
17. van der Jagt DJ, Harrison JM, Ratliff DM, Hunsaker LA, van der Jagt DL. Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin Biochem 2001; 34 (4): 265-70.
18. Dincer Y, Akcay T, Alademir Z, Ilkova H. Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. Metabolism 2002, 51(10): 1360-2.
19. Dumaswala UJ, Zhuo L, Mahajan S et al. Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBC. Am J Physiol Cell Physiol 2001; 280 (4): C867-73.
20. Manuel y Keenoy B, Vertommen J, De Leeuw I. Divergent effects of different oxidants on glutathione homeostasis and protein damage in erythrocytes from diabetic patients: effects of high glucose. Mol Cell Biochem 2001; 225 (1): 59-73.
21. Memisogullari R, Taysi S, Bakan E, Capoglu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 2003; 21 (3): 291-6.
22. Parthiban A, Vijayalingam S, Shanmugasundaram KR, Mohan R. Oxidative stress and the development of diabetic complications - antioxidants and lipid peroxidation in erythrocytes and cell membrane. Cell Biol Int 1995; 19 (12): 987-93.
23. Nwose EU, Jelinek HF, Richards RS, Kerr PG. Changes in the erythrocyte glutathione concentration in the course of diabetes mellitus. Redox Rep 2006; 11 (3): 99-105.
24. Vijayalingam S, Parthiban A, Shanmugasundaram KR, Mohan V. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabet Med 1996; 13 (8): 715-9.
25. Nwose EU, Jelinek HF, Richards RS, Kerr PG. Changes in oxidative stress markers during the progression of diabetes mellitus (Abstract). Free Radic Res 2006; 40 (S1): 138.
26. Matteucci E, Rossi L, Mariani S et al. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives. Nutr Metab Cardiovasc Dis 2002; 12 (4):184-9.
27. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54 (6): 1615-25.
28. Higgins C. Diabetes, hyperglycaemia and cardiovascular disease. The Biomedical Scientist 2006; 50 (2): 106-8.
29. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003; 42 (6): 1075-81.
30. Ziegler D, Sohr CGH, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 2004; 27 (9): 2178-83.
31. Felton A. Prediabetes: the challenge to society. Eur Diabetes Nurs 2005; 2 (2): 87-8.
32. Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 2006; 47 (1): 65-71.
33. Aboud M, Low J, Bonar R et al. QAPD-dimer questionnaire report. Australia: RCPA Haematology QAP: 2003.
34. Ceconi C, Boraso A, Cargnoni A, Ferrari R. Oxidative stress in cardiovascular disease: myth or fact? Arch Biochem Biophys 2003; 420 (2): 217-21.
35. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001; 54 (3): 176-86.
36. Tian N, Rose RA, Jordan S, Dwyer TM, Hughson MD, Manning RD. N-acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension. J Hypertens 2006; 24 (11): 2263-70.
37. Lehmann HP, Henry JB. SI units. In: Henry JB ed. Clinical diagnosis and management by laboratory methods 17th edn. Canada: WB Saunders, 2001: 1433.
38. Jain SK, McVie R, Smith T. Vitamin E supplementation restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children. Diabetes Care 2000; 23 (9): 1389-94.